End‐of‐life quality metrics among medicare decedents at minority‐serving cancer centers: A retrospective study. (11th January 2020)

• Record Type: Journal Article
• Authors: Wasp, Garrett T.; Alam, Shama S.; Brooks, Gabriel A.; Khayal, Inas S.; Kapadia, Nirav S.; Carmichael, Donald Q.; Austin, Andrea M.; Barnato, Amber E.
• Is Part Of: Cancer medicine. Volume 9:Number 5(2020)
• Page Start: 1911
• Page End: 1921
• Publication Date: 2020-01-11
• Subjects: cancer -- end‐of‐life quality -- minority -- treatment intensity; 616.994005
• DOI: 10.1002/cam4.2752
• Languages: English
• ISSNs: 2045-7634

Abstract

Abstract: Background: We calculated the performance of National Cancer Institute (NCI)/National Comprehensive Cancer Network (NCCN) cancer centers' end‐of‐life (EOL) quality metrics among minority and white decedents to explore center‐attributable sources of EOL disparities. Methods: We conducted a retrospective cohort study of Medicare beneficiaries with poor‐prognosis cancers who died between April 1, 2016 and December 31, 2016 and had any inpatient services in the last 6 months of life. We attributed patients' EOL treatment to the center at which they received the preponderance of EOL inpatient services and calculated eight risk‐adjusted metrics of EOL quality (hospice admission ≤3 days before death; chemotherapy last 14 days of life; ≥2 emergency department (ED) visits; intensive care unit (ICU) admission; or life‐sustaining treatment last 30 days; hospice referral; palliative care; advance care planning last 6 months). We compared performance between patients across and within centers. Results: Among 126, 434 patients, 10, 119 received treatment at one of 54 NCI/NCCN centers. In aggregate, performance was worse among minorities for ED visits (10.3% vs 7.4%, P < .01), ICU admissions (32.9% vs 30.4%, P = .03), no hospice referral (39.5% vs 37.0%, P = .03), and life‐sustaining treatment (19.4% vs 16.2%, P < .01). Despite high within‐center correlation for minority and white metrics (0.61‐0.79; P < .01), five metrics demonstrated worse performance as the concentration of minorities increased: ED visits ( P = .03), ICU admission ( P < .01), no hospice referral ( P < .01), and life‐sustaining treatments ( P < .01). Conclusion: EOL quality metrics vary across NCI/NCCN centers. Within center, care was similar for minority and white patients. Minority‐serving centers had worse performance on many metrics. Abstract : We evaluated end‐of‐life quality metrics by minority serving status at NCI/NCCN cancer centers. We found higher minority‐serving status associated with worse end‐of‐life quality on some but not all measures. However, at any given cancer center, care was similar for minority and white patients.